CA
BIIB icon

Continental Advisors’s Biogen BIIB Stock Holding History

Continental Advisors’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-2,377
Closed -$636K – 84
2020
Q2 		$636K Hold
2,377
– – 0.34% 68
2020
Q1 		$752K Hold
2,377
– – 0.56% 60
2019
Q4 		$705K Sell
2,377
-800
-25% -$222K 0.34% 66
2019
Q3 		$740K Hold
3,177
– – 0.44% 60
2019
Q2 		$743K Hold
3,177
– – 0.42% 63
2019
Q1 		$751K Sell
3,177
-523
-14% -$165K 0.35% 73
2018
Q4 		$1.11M Buy
+3,700
New +$1.18M 0.34% 76

Other funds holding BIIB

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Continental Advisors's BIIB Position: Q3 2020 in Review

Continental Advisors sold out of Biogen (BIIB) in Q3 2020, closing a stake of 2,377 shares — an estimated $636K sold.

Continental Advisors first reported a position in BIIB in Q4 2018 and held it in 7 quarters. The position peaked at $1.11M in Q4 2018. 1,051 funds tracked by Wall St. Rank hold BIIB as of Q3 2020.

  • Continental Advisors reported no remaining Biogen position as of Q3 2020 after selling out during the quarter.
  • Continental Advisors sold 2,377 Biogen shares in Q3 2020, an estimated $636K.
  • Continental Advisors first reported a position in Biogen in Q4 2018 and held it in 7 quarters.
  • Continental Advisors's Biogen position peaked at $1.11M in Q4 2018.
  • 1,051 funds tracked by Wall St. Rank held Biogen as of Q3 2020.

Based on Continental Advisors's 13F filing for Q3 2020, filed 16 Nov 2020.